Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT | BSE: 524742 | ISIN: INE475E01026 | Industry: Pharmaceuticals
| Mid-range Performer

2022.0000 4.20 (0.21%)

NSE Jul 07, 2025 13:43 PM

43.61% Gain from 52W Low

Volume: 49,713

Caplin Point Laboratories Ltd.

14 May 2025

2022.00

0.21%

Company Update

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release regarding receipt of USFDA Approval is attached herewith.

More from Caplin Point Laboratories Ltd.

Recommended

Market trades flat, IndusInd Bank's net advances decline 3.9% YoY to Rs 3.5 lakh crore in Q1FY26

Trendlyne Marketwatch | 07 Jul 2025, 01:41PM

Five Interesting Stocks Today - July 04, 2025

The Baseline | 04 Jul 2025

Caplin Point Laboratories maintains export momentum, expands ambitions to new markets